Several factors probably have some role in determining the volume of the effectively ventilated pulmonary capillary bed, including pulmonary blood flow, pulmonary vascular pressures, pulmonary blood volume, alveolar and blood gas tensions, and mechanical effects of ventilation.
Subjects. These studies were carried out in a group of 17 trained, normal, male subjects with an age range from 22 to 34 and body surface area range from 1.85 to 2.20 m2. All studies were carried out no sooner than 3 hours after a light meal and after the subjects had rested at least 30 minutes in the laboratory.
Experimental conditions. Observations were made with the subject either supine or sitting, as required by the specific experimental procedure. Data obtained with the subject in different postures were collected on separate days and are not used for comparison. Observations were made before and beginning 10 minutes after the iv administration of 2.0 mg of atropine sulfate.
Several subjects were studied before and during pressure-suit inflation over the lower part of the body, both before and after the administration of atropine sulfate. The suit used is a single-chamber, balloon-type garment 1 that covers the feet, legs, and abdomen and can be inflated to the desired pressure within 5 seconds by a standard Air Force G valve. The suit was laced on the subject carefully to provide even distribution of pressure. All determinations for comparison with those made during suit inflation were carried out with the subject wearing the laced but uninflated suit. All determinations made during suit inflation were carried out after the suit had been inflated to a pressure of 100 mm Hg for 30 seconds, a pressure which, in previous studies, produced a mean rise in central venous pressure of 25 mnm Hg in seated subjects (4) and increases of 1.35 mm Hg in intrathoracic pressure, 5 mm Hg in gastric pressure, and 18 mm Hg in rectal pressure in supine subjects (5) .
Subjects were trained to keep the glottis open during suit inflation to avoid a Valsalva maneuver.
Positive-pressure breathing was carried out from a closed system consisting of a 200-L drum, a Douglas valve, an underwater exhaust for flushing the system, and a CO2 absorber in the expiratory line ( Figure 1 ). Because of the large volume of the system in relation to the tidal volume and because of a high air-flow rate through an underwater exhaust, respiratory pressure fluctuations in the system were minimal. Regulation of the rate of inflow of compressed air further regulated the pressure in the system. Pulmonary diffusing capacity was measured before and 2 minutes after beginning positive-pressure breathing.
Hemodynamic measurements. Cardiac output was determined in duplicate in the supine position by the indocyanine green dilution method with a Gilford IR 103 densitometer. Dye inj ections were made into the pulmonary artery during the end-expiratory phase of respiration. Cardiac output was calculated by the Hamilton semilog replotting method (6) . Duplicate determinations of cardiac output by this method are reproducible with a mean difference of 3.8% in this laboratory. Duplicate determinations of cardiac output during maintained inflation of the G suit or during positive-pressure breathing showed no greater variability if the dye injections were made during the period 30 seconds to 5 minutes after G-suit inflation or 1 to 3 minutes after beginning positive-pressure breathing. This suggests that within these time limits a reasonably steady state is attained so that the dye dilution method may be used to measure flow reliably. Intravascular pressures were recorded by Statham P-23D transducers and a multichannel recording system. Pulmonary artery, right atrial, and brachial arterial pressures were recorded simultaneously, referred to the midthoracic level, electronically integrated, and recorded over several respiratory cycles.
Pulmonary blood volume estimations. Changes in pulmonary blood volume after atropine were estimated by the method described by Bondurant, Hickam, and Isley (7) and by Weissler, McCraw, and Warren (8) . A Nuclear-Chicago 183-B scaling unit, 1810 radiation analyzer, and DS5-1 probe scintillation counter 2 were used with the 200 collimator. A convenient area in the right mid-lung field, well away from the mediastinal region and well above the diaphragm was selected for counting and marked on the skin. The collimator was applied directly to the skin in an axis perpendicular to the frontal plane of the body at a measured distance from the table top. After background counting over this area, 50 .uc of P`3-albumin was injected intravenously.
Twenty minutes later, counting was begun over the same region and then repeated 10 minutes after the iv administration of 2.0 mg of atropine. In all cases, the counting rate was at least eight times the background rate. Three or more counting periods with a minimum of 1,680 counts each were used before and again after atropine. Between periods, the probe was removed from the skin, redirected, and replaced so that variability in probe placement and orientation could be made random.
The variability among such periods was 2.4 ± 1.5%o.
Further extension of the time allowed for mixing of the 2 Nuclear-Chicago Corp., Des Plaines, Ill.
FIG. 1. APPARATUS FOR POSITIVE-PRESSURE BREATHING.
A = CO. absorber; B = underwater exhaust (pressure in the system is determined by the depth of the exhaust tube under water; pressure fluctuations are minimized by keeping a high flow rate); C = three-way valves; D = bag for collecting alveolar sample; E = Douglas valve; F = pneumotachograph; and G = gas bag containing 0.4% CO. Pressure is maintained by constant flow of compressed air, and recorded directly from a Statham P-23D strain gauge. administered I13`-albumin did not result in a change in the counting rate; consequently, altered counting rates observed after atropine do not represent further dilution of the administered dose. As was observed by Bondurant, Hickam, and Isley (7) and by Weissler box around the bag containing the inspired mixture was not connected to a spirometer, but rather to the positivepressure breathing system already described (Figure 1 ), so that when measurements were made during pressure breathing, the gas mixture was inspired at the pressure at which the subject had been breathing. A pneumotachograph was interposed in the airway near the mouthpiece, and respiratory flow was integrated and recorded on a photographic recorder for determination of the inspired volume and breath-holding time. The apparatus dead space, which is included in the alveolar volume (VA), was small (< 100 ml) and constant under all conditions. By having the subject regulate the inspired volume, it was possible, in an individual subject, to Lung compliance (CL). CL was measured by a linear pneumotachograph-integrator system and an esophageal balloon as described by Mead and Whittenberger (15) . The expressed values for CL represent the mean of values obtained over six to ten slow tidal volumes. Just before each determination, the subject made full inspirations so that the CL changes that Ferris and Pollard (16) found associated with quiet breathing could be avoided. When CL was determined during G-suit inflation, the subjects breathed into a recording spirometer so placed that they were able to observe their respiratory ex- (17, 18) . Arterial Pco2 and the Pco, of mixed expired gas were determined with a Pco2 electrode system.3 VD(phyS) was determined by the method of Riley and co-workers (19) in seated subjects before and 10 minutes after administration of atropine.
Lung volumes and airway resistance. FRC and airway resistance were determined in the total body plethysmograph by the techniques described by DuBois and associates (20) and DilBois, Botelho, and Comroe (21) . Ex- (22) .
Statistics. The effects of atropine, G-suit inflation, and positive-pressure breathing were examined statistically by the "paired comparison" t, with each subject serving as his own control (23) .
RESULTS
Hemodynamic effects of atropine. After atropine, in 13 subjects, cardiac index increased (2.96 + 0.42 to 3.64 + 0.74 L per minute per M2, p = 0.01), heart rate increased (65 + 9 to 104 ± 11 beats per minute, p < 0.001), stroke index decreased (47 + 6 to 35 + 8 ml per M2, p < 0.001), mean right atrial pressure decreased (7 + 2 to 4 ± 2 mm Hg, p < 0.001), and mean pulmonary artery pressure decreased (19 + 5 to 14 + 4 mm Hg, p = 0.005) (Table II) .
G-suit inflation did not alter cardiac index either before or after atropine administration (Table  III) . Before atropine, mean right atrial pressure, measured 30 seconds after suit inflation, was consistently increased (7 + 2 to 15 ± 5 mm Hg, p = 0.01). After atropine, suit inflation produced a smaller increase in right atrial pressure (4 ± 2 to 7 ± 3 mm Hg, p = 0.01).
Mean pulmonary artery pressure was increased by suit inflation (19 ± 5 to 26 ± 4 mm Hg, p = 0.01). After atropine, mean pulmonary artery pressure was increased only to the preatropine level (14 + 5 to 19 ± 6 mm Hg, p = 0.01).
Pulmonary blood volume. The data of Table  IV demonstrate a consistent decrease, averaging 9.2 ± 3.9%o, in the counts detected over the right mid-lung field after atropine in six supine subjects.
DL and V,. The data in Tables V and VI (Table V) . After atropine, then, suit inflation increased both DL and V,, but not to the high level attained before atropine. Table I) .
Summary of results. Table VIII summarizes the effects of atropine, G-suit inflation, and positive-pressure breathing.
DISCUSSION
In the present study, the iv administration of atropine sulfate not only increased heart rate and (24) previously reported no increase in cardiac output with G-suit inflation. Since all these subjects were supine when studied, the data are not at variance with those of Weissler, Leonard, and Warren (25) , who found an increase in cardiac index during G-suit inflation in tilted subjects after atropine. The absence of an increase in cardiac index as a result of an increase in right atrial pressure produced by G-suit inflation for 30 seconds is consistent with the observations of others (26, 27) that acute elevation of previously normal right atrial and pulmonary vascular pressures by iv infusion does not consistently increase cardiac output in normal subjects. A transient increase in cardiac output during the first 30 seconds after G-suit inflation is not excluded. In the present study, G-suit inflation caused a mean increase in central venous pressure of 8 mm Hg in eight supine subjects. Previous observations in similar subjects have shown that intrapleural pressure rises only an average of 1.35 mm Hg during G-suit inflation (5). After atropine, however, the increase in right atrial pressure produced by G-suit inflation was diminished. Two alternative explanations are suggested for the decrease in central vascular pressure after atropine and for the difference in the effect of G-suit inflation: a) after atropine, blood shifts out of the central vascular reservoir into an area that is not effectively compressed by the G suit, or b) after atropine, the compliance of the pulmonary vascular reservoir is increased so that blood is contained at a lower pressure, and the blood transferred to the lungs by G-suit inflation is accommodated at a lower pressure.
Our observations with the external counting technique for estimation of change in pulmonary blood volume (Table IV) indicate that there is less blood in the lungs of supine subj ects after atropine administration and support the concept that the shift of blood is away from the lung. DL and V,, whether measured in seated or supine subjects, were also decreased after atropine administration. Acute central vascular engorgement produced by G-suit inflation moves blood into the lungs (7) and increases DL (4) , again demonstrated in the present study. In these subjects, G-suit inflation after atropine increased central vascular pressures only to about the levels present before atropine was given and caused increases in DL and V, to much lower levels than those that were attained during G-suit inflation before atropine.
Fenn, Otis, Rahn, Chadwick, and Hegnauer (28) have shown that there is a shift of blood out of the thorax during positive-pressure breathing. Positive-pressure breathing at 10 mm Hg in normal supine men does not affect cardiac output (5). This does not imply that greater amounts of positive pressure would not decrease cardiac output (29) . In the present study, this procedure was associated with decreases in DL and V,. After atropine, DL and V, were not further decreased by positive-pressure breathing. These decreases in DL and V, during 10 mm Hg positivepressure breathing are not unlike changes previously observed during Valsalva maneuvers (4, 10) .
The absence of changes in FRC, slowly ventilated space (Vs), and arterial oxyhemoglobin saturation along with the decreased airway resistance after atropine provide evidence that the effects of atropine on DL are not the result of restricted distribution of gas inspired for the DL measurement.
These observations of the effects of atropine on DL and V0 have certain implications concerning over-all pulmonary capillary function. In 1915, Krogh (12) observed an increase in DL during exercise. The increase during exercise has not been explained (24) . It is known that hyperventilation does not increase breath-holding DL (24) and that neither breath-holding nor steadystate DL are increased by acute increases in pulmonary blood flow in man (24, 30) . In fact, as was pointed out by Hatch (31) , consideration of the CO capacity of blood and the rate of CO diffusion suggests that increased pulmonary blood flow should not affect DLCO at low alveolar CO tensions, unless there is an associated increase in the volume of blood actually involved in gas exchange at any instant in time. In other words, for an increased pulmonary blood flow to increase DL,,, either the area for diffusion, or the volume of blood into which gas is diffusing at any instant must increase, and these two are geometrically related factors. Observations thus far available demonstrate only two naturally occurring situations of increased blood flow that are associated with increased V, and DL: the increased flow associated with atrial septal defect (32) These observations with atropine tend to separate the factors of pressure and flow as determinants of DL in man and suggest that DL is more dependent on pulmonary transmural pressure.
This does not imply that pulmonary vascular pressure is the sole hemodynamic determinant of acute changes in DL. The instantaneous pulmonary capillary blood volume certainly increases with moderate exercise, whereas in normal man there is little or no increase in pulmonary arterial pressure with moderate exercise (36, 37) . Such factors as the evenness of distribution of perfusion with regard to ventilation, the compliance of the pulmonary vascular bed, and the effect of systemic venous activity may be of prime importance, but are as yet unresolved problems.
It is uncertain from the present data whether the events occurring in the pulmonary vascular bed after atropine administration are specific direct effects of atropine, or reflect pressure responses to actions of atropine elsewhere. The observed association of decreased DL, VC, and pulmonary blood volume with decreased pulmonary arterial pressure and increased cardiac output suggests that the changes in the pulmonary vascular bed are in response to pooling of blood elsewhere.
Severinghaus and Stupfel (38) found an increase in anatomical dead space in man after atropine and interpreted this change as evidence of bronchomotor tone and an effect of atropine on this tone. Our finding of decreased airway resistance after atropine is in general agreement with this concept. The observed increase in VD(Ph,8) could reflect an enlargement of anatomic airway volume. The possibility of increased alveolar dead space associated with uneven distribution of perfusion and ventilation after atropine is not excluded, although the small increase in VD(phy8) suggests that total closure of pulmonary capillaries must not contribute greatly to the decreased DL and V, observed. This implies a more evenly distributed decrease in pulmonary capillary volume without actual capillary closure.
The dependence in man of dynamic CL upon pulmonary vascular pressure, or volume, or both, was shown by Bondurant and co-workers (7, 39, 40) , who produced acute central vascular engorgement by G-suit inflation and decreased CL by this maneuver. The effects of atropine on CL suggest that, just as increased pulmonary vascular pressures decrease CL, decreased pulmonary vascular pressures and volume increase CL.
The observed association of an increase in dynamic CL and a decrease in airway resistance after atropine suggests that the change in CL might be the consequence of more even distribution of the inspired air, but the absence of change in the slowly ventilated component of the FRC after atropine suggests that the change in CL is not caused by altered distribution of ventilation. Furthermore, a change in CL caused by decreased airway resistance would suggest that CL, in normal men, is affected by breathing frequency and that CL should increase at decreased breathing frequencies; however, Otis and co-workers (41) found that CL is not frequency dependent in normal men. It would seem, therefore, that the observed increase in CL after atropine is not the result of the decreased airway resistance. Since atropine produced no change in FRC, the change in CL after atropine cannot be attributed to a change in lung volume.
The possibility cannot be denied that the observed change in CL after atropine is not real, but is the result of a change in esophageal compliance. If atropine increased the rigidity of the esophagus, similar changes in CL measured by this method would be observed. The information available concerning the effects of atropine on alimentary smooth muscle, however, suggests that the esophagus should become more relaxed after atropine, (42) . Consequently, subject to the inherent reservations associated with the use of the esophagus as a site for pressure measurement in respiratory mechanics, it would seem that the observed increase in CL after atropine is dependent upon the decreased pulmonary vascular pressure and volume after atropine.
These observations of the effects of atropine on CL, DL, V,, and pulmonary blood volume seem to substantiate the thought that atropine, despite its associated increase in cardiac output, reduces the actual volume of blood in the lung and certainly reduces the volume available for gas exchange. These observations do not define the site to which blood has been translocated after atropine, nor the mechanisms involved. The plethysmographic observations of Horsley and Eckstein (3), who found an increased extremity venomotor tone and decreased extremity venous volume after atropine, suggest that blood is also shifted away from the extremities, so by exclusion, a shift to the splanchnic region seems likely. It is tempting to consider this effect of atropine the result of its parasympatholytic action. There is evidence, however, that the effects of atropine are more complex and that atropine may, in large doses, have actions similar to sympathetic ganglionic blocking agents (4345).
SUM MARY
In normal supine subjects, atropine increases cardiac index and decreases right atrial pressure and pulmonary artery pressure. Changes in pulmonary blood volume, estimated by an external I131-counting technique, suggest that atropine causes a redistribution of the blood volume away from the lung.
With the decrease in pulmonary vascular pressures and volume, pulmonary diffusing capacity (DL) and pulmonary capillary volume (V,) decrease, whereas lung compliance (CL) increases.
These changes are not the result of altered distribution of ventilation or changes in lung volume.
Acute pulmonary vascular engorgement produced by G-suit inflation increases right atrial pressure, pulmonary artery pressure, DL, and V0 and decreases CL. Similar, though smaller, changes are produced by G-suit inflation after atropine.
Continuous positive-pressure breathing, a procedure known to move blood out of the chest, decreases DL and V, These findings suggest that atropine causes a shift of blood out of the lungs into an area where it is not effectively mobilized by G-suit inflation. A specific effect of atropine on the pulmonary vasculature cannot be excluded.
This study demonstrates, in man, the dependence of DL and V, on pulmonary vascular pressures, or volume, or both, and their relative independence of cardiac output.
The decrease in CL after atropine is independent of change in lung volume or distribution of ventilation and probably is a further manifestation of the dependence of CL on pulmonary vascular pressure.
